Literature DB >> 15636691

Neurologic complications of plasma cell disorders.

Jan Drappatz1, Tracy Batchelor.   

Abstract

Plasma cell disorders are associated with a wide spectrum of neurologic complications that predominantly involve the peripheral nervous system. Distinct clinical syndromes have been recognized, and antibodies to several glycoproteins of the peripheral nervous system have been identified. The main clinical, laboratory, immunologic, and pathologic features of neurologic complications that occur in patients with monoclonal gammopathies of unknown significance, multiple myeloma, plasmacytoma, plasma cell leukemia, Waldenstrom's macroglobulinemia, and immunoglobulin-related amyloidosis are summarized in this review. Knowledge of the pathogenesis in this group of disorders has increased in recent years, allowing better diagnosis and treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15636691     DOI: 10.3816/clm.2004.n.022

Source DB:  PubMed          Journal:  Clin Lymphoma        ISSN: 1526-9655


  4 in total

1.  Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy.

Authors:  Elisabeth G Vichaya; Xin Shelley Wang; Jessica A Boyette-Davis; Tito R Mendoza; Zijing He; Sheeba K Thomas; Nina Shah; Loretta A Williams; Charles S Cleeland; Patrick M Dougherty
Journal:  Cancer Chemother Pharmacol       Date:  2013-03-31       Impact factor: 3.333

Review 2.  Does my patient with a serum monoclonal spike have multiple myeloma?

Authors:  Giada Bianchi; Irene M Ghobrial
Journal:  Hematol Oncol Clin North Am       Date:  2012-04       Impact factor: 3.722

Review 3.  Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations.

Authors:  Bilal Mohty; Jean El-Cheikh; Ibrahim Yakoub-Agha; Philippe Moreau; Jean-Luc Harousseau; Mohamad Mohty
Journal:  Haematologica       Date:  2010-02       Impact factor: 9.941

4.  Nonsystemic vasculitic neuropathy in a patient with IgG-monoclonal gammopathy of undetermined significance: A case report.

Authors:  Ryuta Kinno; Yuyuko Osakabe; Seiya Takahashi; Shinji Kurokawa; Yoshiyuki Owan; Kenjiro Ono; Yasuhiko Baba
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.